Article
Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
Molecular carcinogenesis - 1 Aug 2020
Liu Xiaowen, Qian Danwen, Liu Hongliang, Abbruzzese James L, Luo Sheng, Walsh Kyle M, Wei Qingyi
Abstract excerpt
Because the peroxisome proliferator-activated receptor (PPAR) signaling pathway is involved in development and progression of pancreatic cancer, we investigated associations between genetic variants of the PPAR pathway genes and pancreatic cancer risk by using three published genome-wide association study datasets including 8477 cases and 6946 controls of European ancestry. Expression quantitative trait loci...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
